1.Rapid Determination of Chimerism Status Using Dihydrorhodamine Assay in a Patient with X-linked Chronic Granulomatous Disease Following Hematopoietic Stem Cell Transplantation.
Hyun Young KIM ; Hee Jin KIM ; Chang Seok KI ; Dae Won KIM ; Keon Hee YOO ; Eun Suk KANG
Annals of Laboratory Medicine 2013;33(4):288-292
Chronic granulomatous disease (CGD) is a rare genetic disease, which is caused by defects in the NADPH oxidase complex (gp91phox, p22phox, p40phox, p47phox, and p67phox) of phagocytes. This defect results in impaired production of superoxide anions and other reactive oxygen species (ROS), which are necessary for killing bacterial and fungal microorganisms and leads to recurrent, life-threatening bacterial and fungal infections and granulomatous inflammation. The dihydrorhodamine (DHR) flow cytometry assay is a useful diagnostic tool for CGD that can detect absent or reduced NADPH oxidase activity in stimulated phagocytes. We report a patient with X-linked CGD carrying a novel mutation of the CYBB gene whose chimerism status following hematopoietic stem cell transplantation (HSCT) has been rapidly determined using the DHR assay. The level of DHR activity correlates well with short tandem repeat PCR analysis. Considering the advantages of this simple, rapid, and cost-effective procedure, serial measurement of DHR assay would facilitate the rapid determination of a patient's engraftment status, as a supplementary monitoring tool of chimerism status following HSCT.
Base Sequence
;
*Chimerism
;
DNA Mutational Analysis
;
Flow Cytometry
;
Granulomatous Disease, Chronic/*diagnosis/*enzymology/genetics/surgery
;
*Hematopoietic Stem Cell Transplantation
;
Homozygote
;
Humans
;
Infant, Newborn
;
Male
;
Membrane Glycoproteins/chemistry/*genetics
;
Mutation
;
NADPH Oxidase/chemistry/*genetics
;
Polymerase Chain Reaction
;
Rhodamines/chemistry/metabolism
2.Solid-phase synthesis and in vitro activity research of tumor-targeting cell-penetrating peptide.
Ji-wen HE ; Hua LI ; Nan JIANG ; Yan TAI ; Qi ZHANG ; Yang YANG ; Gui-hua CHEN
Journal of Southern Medical University 2011;31(2):201-204
OBJECTIVETo synthesize a tumor-targeting cell-penetrating peptide (CPP) and evaluate its biological activity and cytotoxicity in vitro.
METHODSWith fluorenylmethyloxycarbonyl (Fmoc) as the protective group of α-amino acid, the tumor-targeting CPP were synthesized with stepwise amino acid extension using solid-phase synthesis method. 5-carboxytetramethylrhodamine was added for fluorescence labeling in the presence of the coupling agents HATU and DMF. The purity of the CPP was measured by high-performance liquid chromatography and its molecular weight measured by mass spectrometry. Fluorescence microscope was used to assess the cell-penetrating activity?of the CPP in hepatocellular carcinoma cell lines SMMC-7721 and normal hepatocellular cell lines LO2. The growth activity of CPP-treated SMMC-7721 cells was measured by MTT assay.
RESULTSWith a purity of 96.05% and a relative molecular mass of 3504.9, the synthesized CPP showed no translocation activity in normal hepatocellular cell lines LO2, but showed strong ability to translocate into SMMC-7721 cells without affecting the biological activity of the cells.
CONCLUSIONUsing Fmoc solid-phase synthesis method, we have successfully synthesized the CPP with tumor-targeting activity.
Cell Line, Tumor ; Cell-Penetrating Peptides ; chemical synthesis ; pharmacology ; Drug Delivery Systems ; Drug Design ; Humans ; Liver Neoplasms ; drug therapy ; metabolism ; pathology ; Matrix Metalloproteinase 2 ; metabolism ; Rhodamines ; chemistry ; Solid-Phase Synthesis Techniques
3.Species-Specific Differences in Rhodamine 6G Accumulation of Candida Isolates Detected by Flow Cytometric Analysis.
Chang Jin MOON ; Jong Hee SHIN ; Da Woon KIM ; Seung Jung KEE ; Soo Hyun KIM ; Myung Geun SHIN ; Soon Pal SUH ; Dong Wook RYANG
The Korean Journal of Laboratory Medicine 2009;29(2):127-134
BACKGROUND: Fluorescent dye Rhodamine 6G (R6G) is a substrate of multidrug resistance pumps and its accumulation is reduced in some azole-resistant Candida isolates with the upregulation of multidrug efflux transporter genes. Despite reports on species-specific differences in azole susceptibility in various Candida species, only a few studies have been reported on the R6G accumulation among clinical isolates of Candida species. In this study, we compared R6G accumulation between six different Candida species. METHODS: The intracellular accumulation of R6G and minimal inhibitory concentrations (MICs) of three triazole agents were investigated in 48 strains of six Candida species (14 C. albicans, 9 C. tropicalis, 8 C. glabrata, 8 C. krusei, 7 C. parapsilosis, and 2 C. haemulonii). R6G accumulation was measured by using flow cytometry and the geometric mean of the fluorescence intensity (GMF) was used to compare the accumulation between the Candida isolates. RESULTS: The GMF values for the C. tropicalis, C. albicans, C. krusei, C. parapsilosis, and C. glabrata isolates were 167.3+/-18.5, 126.9+/-6.6, 88.5+/-18.5, 50.8+/-7.0, and 38.1+/-3.9, respectively. C. glabrata had a significantly lower mean GMF than all the other Candida species (P<0.05). While some Candida strains with trailing growth phenomenon and increased fluconazole MIC did not have a reduced GMF, three Candida strains with increased MICs to all three triazole agents had a reduced GMF. CONCLUSIONS: This study found species-specific differences in R6G accumulation in Candida. In addition, the intracellular R6G accumulation can be used to investigate the drug efflux mechanism in azole-resistant Candida strains.
Antifungal Agents/pharmacology
;
Azoles/pharmacology
;
Candida/chemistry/isolation & purification/*metabolism
;
Candidiasis/drug therapy
;
Drug Resistance, Fungal
;
Flow Cytometry/*methods
;
Fluconazole/pharmacology
;
Fluorescent Dyes/*analysis
;
Humans
;
Microbial Sensitivity Tests
;
Rhodamines/*analysis
;
Species Specificity
4.Comparative transcriptomic analysis reveals adriamycin-induced apoptosis via p53 signaling pathway in retinal pigment epithelial cells.
Yu-Chen LIN ; Ze-Ren SHEN ; Xiao-Hui SONG ; Xin LIU ; Ke YAO
Journal of Zhejiang University. Science. B 2018;19(12):895-909
OBJECTIVE:
This paper applied a transcriptomic approach to investigate the mechanisms of adriamycin (ADR) in treating proliferative vitreoretinopathy (PVR) using ARPE-19 cells.
METHODS:
The growth inhibitory effects of ADR on ARPE-19 cells were assessed by sulforhodamine B (SRB) assay and propidium iodide (PI) staining using flow cytometry. The differentially expressed genes between ADR-treated ARPE-19 cells and normal ARPE-19 cells and the signaling pathways involved were investigated by microarray analysis. Mitochondrial function was detected by JC-1 staining using flow cytometry and the Bcl-2/Bax protein family. The phosphorylated histone H2AX (γ-H2AX), phosphorylated checkpoint kinase 1 (p-CHK1), and phosphorylated checkpoint kinase 2 (p-CHK2) were assessed to detect DNA damage and repair.
RESULTS:
ADR could significantly inhibit ARPE-19 cell proliferation and induce caspase-dependent apoptosis in vitro. In total, 4479 differentially expressed genes were found, and gene ontology items and the p53 signaling pathway were enriched. A protein-protein interaction analysis indicated that the TP53 protein molecules regulated by ADR were related to DNA damage and oxidative stress. ADR reduced mitochondrial membrane potential and the Bcl-2/Bax ratio. p53-knockdown restored the activation of c-caspase-3 activity induced by ADR by regulating Bax expression, and it inhibited ADR-induced ARPE-19 cell apoptosis. Finally, the levels of the γ-H2AX, p-CHK1, and p-CHK2 proteins were up-regulated after ADR exposure.
CONCLUSIONS
The mechanism of ARPE-19 cell death induced by ADR may be caspase-dependent apoptosis, and it may be regulated by the p53-dependent mitochondrial dysfunction, activating the p53 signaling pathway through DNA damage.
Apoptosis
;
Caspases/metabolism*
;
Cell Proliferation
;
Cell Survival/drug effects*
;
Doxorubicin/pharmacology*
;
Flow Cytometry
;
Gene Expression Profiling
;
Gene Expression Regulation
;
Humans
;
Membrane Potential, Mitochondrial
;
Oligonucleotide Array Sequence Analysis
;
Oxidative Stress/drug effects*
;
Phosphorylation
;
Propidium/chemistry*
;
RNA, Small Interfering/metabolism*
;
Retinal Pigment Epithelium/metabolism*
;
Rhodamines/chemistry*
;
Signal Transduction/drug effects*
;
Transcriptome
;
Tumor Suppressor Protein p53/metabolism*
;
Vitreoretinopathy, Proliferative/drug therapy*